- Home
- GWRE vs ICLR Comparison
GWRE vs ICLR Comparison
Compare GWRE & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GWRE | ICLR |
|---|---|---|
| Founded | 2001 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4B | 14.3B |
| IPO Year | 2012 | 1998 |
Fundamental Metrics
Financial Performance| Metric | GWRE | ICLR |
|---|---|---|
| Price | $199.72 | $177.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 14 |
| Target Price | ★ $271.69 | $202.38 |
| AVG Volume (30 Days) | ★ 1.1M | 1.0M |
| Earning Date | 12-03-2025 | 10-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 191.31 | N/A |
| EPS | 1.06 | ★ 7.47 |
| Revenue | $1,272,197,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $18.42 | N/A |
| Revenue Next Year | $15.17 | $0.76 |
| P/E Ratio | $186.16 | ★ $23.91 |
| Revenue Growth | ★ 22.80 | N/A |
| 52 Week Low | $165.09 | $125.10 |
| 52 Week High | $272.60 | $228.29 |
Technical Indicators
Market Signals| Indicator | GWRE | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 39.09 | 47.85 |
| Support Level | $189.34 | $178.80 |
| Resistance Level | $207.69 | $185.31 |
| Average True Range (ATR) | 8.01 | 6.67 |
| MACD | -0.13 | -0.89 |
| Stochastic Oscillator | 25.02 | 15.55 |
Price Performance
Historical ComparisonAbout GWRE Guidewire Software Inc.
Guidewire Software provides cloud-based software solutions for property and casualty insurers. The flagship product, InsuranceSuite is a system of record and comprises ClaimCenter, a claims management system; PolicyCenter, a policy management system including policy definitions, quotas, issuance, maintenance, and renewal; and BillingCenter, for billing management, payment plans, and agent commissions. The company also offers InsuranceNow, a midmarket offering, as well as a variety of other add-on applications and services.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.